Civic AI
Procurement intelligence
Federal contract award
TO CONDUCT NON-CLINICAL GOOD LABORATORY PRACTICE (GLP) IN VIVO GENOTOXICITY AND REPRODUCTIVE TOXICOLOGY AND GLP DEVELOPMENT AND REPRODUCTIVE (DART) TOXICOLOGY STUDIES.
ARISAN THERAPEUTICS INC · Department of Health and Human Services
- Value
- $3,692,037
- Start
- Sep 22, 2023
- End
- Dec 31, 2026
- Action date
- Jan 20, 2026
- PIID
- 75N93023C00051
- Status
- active
- NAICS
- 541715 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
- Place of performance
- CARLSBAD, CA
- Award type
- DEFINITIVE CONTRACT
Description
TO CONDUCT NON-CLINICAL GOOD LABORATORY PRACTICE (GLP) IN VIVO GENOTOXICITY AND REPRODUCTIVE TOXICOLOGY AND GLP DEVELOPMENT AND REPRODUCTIVE (DART) TOXICOLOGY STUDIES.
Need modifications, related awards, and vendor peers? Open the full award workspace.